Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05676463 · ClinicalTrials.gov registry record · Phase 2
MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer
A Phase 2 study, sponsored by Thomas Jefferson University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT05676463 is a Phase 2 study that was terminated before completion, run by Thomas Jefferson University. The registered enrollment target is 6 participants.
The verdict
NCT05676463, a Phase 2 study, was terminated before completion, sponsored by Thomas Jefferson University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
This phase II trial tests whether magnetic resonance imaging (MRI)-guided hypofractionated radiation therapy works to reduce treatment time and side effects in patients with high risk prostate cancer. MRI-guided hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time directly to diseased tissue, reducing damage to healthy tissue. Using MRI-guided radiation therapy on areas of the prostate and pelvic lymph nodes may shorten overall treatment time compared to the longer standard of care therapy and may reduce the number and/or duration of side effects.
Interventions
- PROCEDURE Computed Tomography
- PROCEDURE Magnetic Resonance Imaging
- DRUG Antiandrogen Therapy
- PROCEDURE PSMA PET Scan
- PROCEDURE MRI-guided Intensity-Modulated Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2022-11-16 |
| Est. Completion | 2025-10-24 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05676463
The ClinicalTrials.gov registry entry for NCT05676463 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Computed Tomography is the first listed.
NCT05676463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05676463 about?
NCT05676463 is a clinical study titled "MRI Guided Radiation Therapy for the Treatment of High Risk Prostate Cancer". This phase II trial tests whether magnetic resonance imaging (MRI)-guided hypofractionated radiation therapy works to reduce treatment time and side effects in patients with high risk prostate cancer. MRI-guided hypofractionated radiation therapy delivers higher doses of radiation therapy over a sho...
What is the current status of trial NCT05676463?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2022-11-16. Estimated completion is 2025-10-24.
What interventions are being tested in trial NCT05676463?
The interventions under investigation include: Computed Tomography (PROCEDURE), Magnetic Resonance Imaging (PROCEDURE), Antiandrogen Therapy (DRUG), PSMA PET Scan (PROCEDURE), MRI-guided Intensity-Modulated Radiation Therapy (PROCEDURE).
Who is sponsoring clinical trial NCT05676463?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.